| |
| |
|
| Insider
Information: |
Gorman Kevin Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
517,112 |
|
|
Indirect Shares
|
57,996 |
|
|
| Direct
Value |
$69,735,050 |
|
|
|
Indirect Value
|
$7,886,876 |
|
|
| Total
Shares |
575,108 |
|
|
| Total
Value |
$77,621,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 0.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-13 |
4 |
OE |
$35.99 |
$199,951 |
D/D |
5,090 |
512,052 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-13 |
4 |
AS |
$133.02 |
$376,700 |
D/D |
(2,832) |
514,596 |
0 |
% |
|
| XNCR |
Xencor Inc |
Director |
• • – |
2024-02-13 |
4 |
B |
$19.12 |
$1,013 |
D/D |
53 |
5,060 |
2.31 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-08 |
4 |
AS |
$134.15 |
$305,052 |
D/D |
(2,274) |
506,962 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-06 |
4 |
AS |
$142.18 |
$432,218 |
D/D |
(3,040) |
504,919 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-31 |
4 |
AS |
$140.69 |
$380,845 |
D/D |
(2,707) |
502,188 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-09 |
4 |
AS |
$134.01 |
$8,311,895 |
D/D |
(62,023) |
499,754 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-09 |
4 |
OE |
$19.59 |
$1,215,031 |
D/D |
62,023 |
561,777 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-08 |
4 |
AS |
$132.44 |
$14,016,523 |
D/D |
(105,835) |
499,754 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-08 |
4 |
OE |
$19.59 |
$2,073,308 |
D/D |
105,835 |
605,589 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-08-21 |
4 |
AS |
$107.40 |
$1,001,816 |
D/D |
(9,328) |
499,754 |
0 |
% |
|
| XNCR |
Xencor Inc |
Director |
• • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,007 |
5,007 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-08 |
4 |
AS |
$104.30 |
$237,185 |
D/D |
(2,274) |
491,365 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-07 |
4 |
AS |
$102.30 |
$2,430,315 |
D/D |
(23,730) |
489,322 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
AS |
$105.68 |
$321,259 |
D/D |
(3,040) |
468,008 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-01-31 |
4 |
AS |
$110.08 |
$297,997 |
D/D |
(2,707) |
465,278 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2022-02-08 |
4 |
AS |
$79.49 |
$180,768 |
D/D |
(2,274) |
462,844 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2022-02-07 |
4 |
AS |
$80.80 |
$703,907 |
D/D |
(8,710) |
460,801 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2021-02-08 |
4 |
AS |
$116.71 |
$1,221,864 |
D/D |
(10,466) |
452,972 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
AS |
$114.16 |
$276,504 |
D/D |
(2,422) |
443,249 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2021-01-08 |
4 |
AS |
$110.21 |
$33,973,877 |
D/D |
(308,250) |
441,071 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2021-01-08 |
4 |
OE |
$8.65 |
$2,667,797 |
D/D |
308,250 |
605,872 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-11-12 |
4 |
AS |
$90.78 |
$307,748 |
D/D |
(3,390) |
441,071 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-08-05 |
4 |
AS |
$118.91 |
$403,101 |
D/D |
(3,390) |
438,021 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-04-24 |
4 |
AS |
$99.45 |
$289,016 |
D/D |
(2,906) |
434,971 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
